Longitudinal non‐adherence predicts treatment escalation in paediatric ulcerative colitis

Abstract

Non-adherence may have affected therapeutic efficacy of standardised mesalazine, thereby contributing to need for treatment escalation. Routine adherence monitoring for at least 6 months following treatment initiation and addressing adherence difficulties early in the disease course are recommended.